Icelandic
Albanian
Arabic
Armenian
Azerbaijani
Belarusian
Bengali
Bosnian
Catalan
Czech
Danish
Deutsch
Dutch
English
Estonian
Finnish
Français
Greek
Haitian Creole
Hebrew
Hindi
Hungarian
Icelandic
Indonesian
Irish
Italian
Japanese
Korean
Latvian
Lithuanian
Macedonian
Mongolian
Norwegian
Persian
Polish
Portuguese
Romanian
Russian
Serbian
Slovak
Slovenian
Spanish
Swahili
Swedish
Turkish
Ukrainian
Vietnamese
Български
中文(简体)
中文(繁體)

hearing loss/krabbamein

Krækjan er vistuð á klemmuspjaldið
Bls 1 frá 2694 niðurstöður

Reversible sensorineural hearing impairment induced by a carotid body tumor.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
A case of a 62-year-old Austrian man having a 25-year history of a right-sided carotid body tumor (CBT) is presented. Three months before being transferred to the University of Vienna for tumor resection the patient developed symptoms of tinnitus, progressive ipsilateral hearing loss and dysphagia.
Sensorineural hearing loss (SNHL) is a significant toxicity experienced by some patients undergoing cisplatin-based chemoradiation therapy for head and neck cancer. Therefore, SNHL risk profiles were created based on demographics, hearing thresholds, and treatment

Sudden hearing loss due to oxaliplatin use in a patient with colon cancer.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Oxaliplatin is used to treat advanced colorectal cancer. Platinum-containing chemotherapeutic agents are known to be ototoxic. However, ototoxicity is rare with newer generation platinum-derived agents, such as oxaliplatin. This case report presents a rare case of sudden unilateral sensorineural

Hearing loss as a late complication of radiotherapy in children with brain tumors.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Late postirradiation hearing loss has been well described in the adult population. Few reports exist on the pediatric population. We conducted a retrospective review of 157 consecutive children with brain tumors treated exclusively with irradiation at St Jude Children's Research Hospital. Twenty-six

Etanercept, a tumour necrosis factor alpha receptor antagonist, and methotrexate in acute sensorineural hearing loss.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Patients with autoimmune inner-ear disease (AIED) are treated with high doses of steroids in the short term when suffering an acute hearing loss. As a consequence, substances such as methotrexate have been employed in the role of steroid-sparing agents. Additionally, it is known that tumour necrosis

Sudden hearing loss induced by acoustic neuroma: significance of small tumors.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
In our series of 111 patients operated on for acoustic neuroma from 1972 to 1990, 21 (18.9%) had sudden hearing loss. The 21 tumors involved were comprised of 9 small, 5 medium, and 7 large tumors. Emphasis is placed on the fact that even a small tumor has the potential to produce sudden hearing
OBJECTIVE To characterize levels of tumor necrosis factor (TNF; formerly known as tumor necrosis factor α), a well-established proinflammatory cytokine, in patients with immune-mediated sensorineural hearing loss (IM-SNHL) and to determine the role of this cytokine in identifying steroid-responsive
OBJECTIVE To evaluate the effect of transtympanic administration of tumor necrosis factor alpha (TNF-alpha) blockers to patients suffering from autoimmune inner ear disease (AIED). METHODS Nonrandomized, prospective pilot study. METHODS Tertiary referral center. METHODS 9 patients (4 men and 5

Hearing loss and complaint in patients with head and neck cancer treated with radiotherapy.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
OBJECTIVE To investigate occurrences of hearing loss and hearing complaints among patients with head and neck tumors who underwent radiotherapy. METHODS Prospective case-control study. METHODS Tertiary care hospital. METHODS Two hundred eighty-two participants underwent evaluation, including 141

The prevalence of hearing loss in children and adolescents with cancer.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
The treatment of cancer in children has several side effects, including ototoxicity. Inner ear structures may be affected and hearing loss may ensue. OBJECTIVE To estimate the prevalence of hearing loss in patients with cancer using the American Speech-Language-Hearing Association (ASHA), the

Pineal region tumor manifesting initially as hearing impairment.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
An 18-year-old male presented with a pineal region germinoma with hearing impairment as the chief complaint. Magnetic resonance image demonstrated a well-enhanced multi-cystic tumor extending into the upper fourth ventricle and wall of the bilateral lateral ventricles. Audiometry revealed bilateral

Radiation-induced hearing impairment in patients treated for malignant parotid tumor.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Radiation-induced hearing loss was evaluated in 21 patients with unilateral malignant parotid tumors treated with surgery and radiotherapy. The contralateral ear was used as a control. Eight patients (38%) were found to have a reduction in static compliance of the tympanic membrane (type B

Acoustic tumor with hearing loss of sudden onset and recovery.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
In many cases of acoustic tumor the hearing loss is gradually progressive, but some cases of acoustic tumor show a sudden onset of hearing loss. In this paper we report two interesting cases of acoustic tumors which were diagnosed as sudden deafness at the first examination. Being treated with

Sensorineural Hearing Loss after Treatment for Head and Neck Cancer: A Review of the Literature.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
Definitive cisplatin-based chemoradiation is increasingly delivered as the treatment of choice for patients with head and neck cancer. Sensorineural hearing loss is a significant long-term side effect of cisplatin-based chemoradiation and is associated with potential major quality of

Endolymphatic sac tumors. A source of morbid hearing loss in von Hippel-Lindau disease.

Aðeins skráðir notendur geta þýtt greinar
Skráðu þig / skráðu þig
OBJECTIVE Isolated reports suggest a possible association of endolymphatic sac tumors (ELSTs), which are extremely rare in the general population, with von Hippel-Lindau disease (VHL). To determine if hearing loss and ELSTs are a component of VHL, we examined prevalence, clinical presentation, and
Skráðu þig á
facebook síðu okkar

Heillasta gagnagrunnur lækningajurtanna sem studdur er af vísindum

  • Virkar á 55 tungumálum
  • Jurtalækningar studdir af vísindum
  • Jurtaviðurkenning eftir ímynd
  • Gagnvirkt GPS kort - merktu jurtir á staðsetningu (kemur fljótlega)
  • Lestu vísindarit sem tengjast leit þinni
  • Leitaðu að lækningajurtum eftir áhrifum þeirra
  • Skipuleggðu áhugamál þitt og vertu vakandi með fréttarannsóknum, klínískum rannsóknum og einkaleyfum

Sláðu inn einkenni eða sjúkdóm og lestu um jurtir sem gætu hjálpað, sláðu jurt og sjáðu sjúkdóma og einkenni sem hún er notuð við.
* Allar upplýsingar eru byggðar á birtum vísindarannsóknum

Google Play badgeApp Store badge